Galenea

Galenea Corp. is a biopharmaceutical company dedicated to developing treatments for central nervous system (CNS) diseases. The company focuses on psychiatric disorders, schizophrenia and calcineurin, obesity, and 5-HT2C agonists. Its products include in vitro and in vivo synaptic function screening and brain slice electrophysiological assays, which involve techniques for recording disease-related neuronal activity in the prefrontal cortex to measure the effects of candidate drugs in animals performing critical memory or cognition-dependent tasks.